Beren Therapeutics Announces FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann Pick Disease Type C February 24, 2026
ND Expert Sean Kassen: Statement on first FDA-approved treatment for Niemann-Pick Type C disease September 23, 2024
